SCHEMBL10909893

SCHEMBL10909893

C=CCOC(=O)CCCCON

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.61
ALDH1A1 P00352 5/20 0.44
GAA P10253 1/20 0.44
EPHX2 P34913 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.38
DGKA P23743 1/20 0.37
MAPT P10636 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
CYP3A4 P08684 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10903309 0.94 TSHR (0.58) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL10906007 0.86 TSHR (0.52) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL153651 0.86 TSHR (0.77) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL3120781 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL10834721 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL11795597 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL11131759 0.84 TSHR (0.74) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL180289 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL5392962 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1
SCHEMBL632341 0.84 TSHR (0.81) TSHRALDH1A1GAAEPHX2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0100900-B1 NOVEL (3.2.0.) BICYCLOHEPTANONE OXIME ETHERS WITH VALUABLE THERAPEUTIC PROPERTIES SYNTEX (U.S.A.) INC. (US) 1986-02-05 EP disclosed
US-4552898-A CARDIOVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-11-12 US disclosed
EP-0100900-A1 Novel (3.2.0.) bicycloheptanone oxime ethers with valuable therapeutic properties SYNTEX (U.S.A.) INC. (US) 1984-02-22 EP disclosed
US-4423068-A (3.2.0) Bicycloheptanone oxime ethers with therapeutic properties SYNTEX (U.S.A.) INC. (US) 1983-12-27 US disclosed